Koštani morfogenetički protein (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Koštani morfogenetički protein" in Serbian language version.

refsWebsite

Global rank Serbian rank

4^th place

8^th place

2^nd place

4^th place

6^th place

5^th place

archive.org

Kodach LL, Wiercinska E, de Miranda NF, Bleuming SA, Musler AR, Peppelenbosch MP, Dekker E, van den Brink GR, van Noesel CJ, Morreau H, Hommes DW, Ten Dijke P, Offerhaus GJ, Hardwick JC (2008). „The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.”. Gastroenterology. 134 (5): 1332—41. PMID 18471510. doi:10.1053/j.gastro.2008.02.059.

Reddi, AH; Reddi, A (2009). „Bone morphogenetic proteins (BMPs): from morphogens to metabologens”. Cytokine & growth factor reviews. 20 (5-6): 341—2. PMID 19900831. doi:10.1016/j.cytogfr.2009.10.015.
Bleuming SA, He XC, Kodach LL, Hardwick JC, Koopman FA, Ten Kate FJ, van Deventer SJ, Hommes DW, Peppelenbosch MP, Offerhaus GJ, Li L, van den Brink GR (2007). „Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice.”. Cancer Research. 67 (17): 8149—55. PMID 17804727. doi:10.1158/0008-5472.CAN-06-4659.
Kodach LL, Wiercinska E, de Miranda NF, Bleuming SA, Musler AR, Peppelenbosch MP, Dekker E, van den Brink GR, van Noesel CJ, Morreau H, Hommes DW, Ten Dijke P, Offerhaus GJ, Hardwick JC (2008). „The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.”. Gastroenterology. 134 (5): 1332—41. PMID 18471510. doi:10.1053/j.gastro.2008.02.059.
Milano F, van Baal JW, Buttar NS, Rygiel AM, de Kort F, DeMars CJ, Rosmolen WD, Bergman JJ, Van Marle J, Wang KK, Peppelenbosch MP, Krishnadath KK (2007). „Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells.”. Gastroeneterology. 132 (7): 2412—21. PMID 17570215. doi:10.1053/j.gastro.2007.03.026.

Reddi, AH; Reddi, A (2009). „Bone morphogenetic proteins (BMPs): from morphogens to metabologens”. Cytokine & growth factor reviews. 20 (5-6): 341—2. PMID 19900831. doi:10.1016/j.cytogfr.2009.10.015.
Bleuming SA, He XC, Kodach LL, Hardwick JC, Koopman FA, Ten Kate FJ, van Deventer SJ, Hommes DW, Peppelenbosch MP, Offerhaus GJ, Li L, van den Brink GR (2007). „Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice.”. Cancer Research. 67 (17): 8149—55. PMID 17804727. doi:10.1158/0008-5472.CAN-06-4659.
Kodach LL, Wiercinska E, de Miranda NF, Bleuming SA, Musler AR, Peppelenbosch MP, Dekker E, van den Brink GR, van Noesel CJ, Morreau H, Hommes DW, Ten Dijke P, Offerhaus GJ, Hardwick JC (2008). „The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.”. Gastroenterology. 134 (5): 1332—41. PMID 18471510. doi:10.1053/j.gastro.2008.02.059.
Milano F, van Baal JW, Buttar NS, Rygiel AM, de Kort F, DeMars CJ, Rosmolen WD, Bergman JJ, Van Marle J, Wang KK, Peppelenbosch MP, Krishnadath KK (2007). „Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells.”. Gastroeneterology. 132 (7): 2412—21. PMID 17570215. doi:10.1053/j.gastro.2007.03.026.